PlexusDx clinicians will review your detailed history, assess your personal risk profile, and may recommend genetic testing or consultation with a cardiologist to determine if semaglutide is safe for you, or if an alternative GLP-1 compound or weight loss strategy is more appropriate
They can also assist in reducing the chances of heart disease and other major health issues
It pairs effectively with other diabetes management strategies and is accessible through prescription referral services like Better You Rx
In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss
If you are pregnant or nursing, please consult your healthcare practitioner before use
The review covers both the statistical significance and real-world implications for daily practice